Abstract
Peritoneal dialysis (PD) treatment of prevalent end-stage kidney disease (ESKD) patients in South Korea declined from a peak of 23% in 2005 to 8% in 2017. Only 13% (119/941) of dialysis facilities offer PD, and PD use ranges from 6% to 13% of their dialysis patients. Low PD utilization in Korea likely is multifactorial and relates to less favorable reimbursement for PD than for facility-based HD, inadequate nephrologist training and/or experience in managing PD patients and an aging ESKD population (45% are aged 65 years or older) who are less likely to be treated with PD in Korea; because previous domestic and international studies have indicated poor outcomes in elderly diabetic patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
